New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BAC;OCN;WIC;NSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2015
07:02 EDTBACBank of America reports Q1 EPS with items 27c, consensus 29c
Reports Q1 revenue $21.2B, consensus $21.5B. Results Include $1.0B, or 6c per share, in annual retirement-eligible incentive costs and $0.5B, or 3c per share, in charges to revenue for market-related net interest income adjustments.
06:11 EDTBACRegulators seek to end 'too big to fail' firms, WSJ reports
Subscribe for More Information
April 14, 2015
15:34 EDTBACNotable companies reporting before tomorrow's open
Subscribe for More Information
15:34 EDTBACBank of America April 16 straddle priced for 3.4% movement into Q1
14:38 EDTBACEarnings Watch: Bank of America to report after mixed reviews from Fed
Subscribe for More Information
14:36 EDTBACBank of America technical comments ahead of earnings
The stock is trading up to resistance at the 50-day moving average, last at $15.95. Since November 2013, the stock has been trading in a range bound largely by $15 at the low and $18 at the high. A break of either end of the range would help guide where shares might trade thereafter. Failing news that is sufficiently bullish or bearish, we could expect the stock to trade in the same range until another catalyst emerges. On better news, resistance above current levels would be at $16.62, $17.22, and then at $18. If the news is more bearish than expected, a breakdown below $15 might be probable. In that event next support levels below $15 as downside objectives would be at $14.37 which is the 52-week low and then at $13.49 and $12.80.
09:13 EDTOCNOn The Fly: Pre-market Movers.
UP AFTER EARNINGS: JPMorgan Chase (JPM), up 1%... Johnson & Johnson (JNJ), up marginally... Triangle Petroleum (TPLM), up 4.2%... Fastenal (FAST), up 5%. ALSO HIGHER: Brainstorm Cell Therapeutics (BCLI), up 13.5% after announcing that it will present NurOwn Phase 2a clinical data at the Academy of Neurology annual meeting... Builders FirstSource (BLDR), up 7.2% after being upgraded to Buy from Hold at Stifel... Solazyme (SZYM), up 7.5% after announcing a strategic agreement with Flotek (FTK)... Cleveland BioLabs (CBLI), up 6.8% after receiving funding recommendation from the Department of Defense... Nordic American Tanker (NAT), up 3.2% after raising quarterly dividend to 38c from 22c... Ocwen (OCN), up 3.8% after reporting preliminary fiscal 2014 results. DOWN AFTER EARNINGS: Wells Fargo (WFC), down just under 1%. ALSO LOWER: Norfolk Southern (NSC), down 5.8% after being downgraded to Hold from Buy at TD Securities... RXi Pharmaceuticals (RXII), down 14.3% after filing to sell $20M of common stock and warrants... Arrowhead Research (ARWR), down 4.5% after being downgraded to Hold from Buy at Jefferies.
07:43 EDTOCNOcwen up 2.3% after reporting preliminary FY14 results
Subscribe for More Information
07:43 EDTOCNOcwen expects to be profitable in FY15
Subscribe for More Information
07:42 EDTOCNOcwen reports preliminary FY14 EPS ($4.18), may not compare to consensus 92c
Subscribe for More Information
07:35 EDTBACBank of America April volatility elevated into Q1 and outlook
Subscribe for More Information
April 13, 2015
09:24 EDTBACBank of America shares are cheap, says Morgan Stanley
Morgan Stanley said its sum of the parts of analysis of Overweight rated Bank of America indicates a value of $21. The firm said Bank of America's current share price implies no value for the wealth management division, which it values at $4.84 per share. Morgan Stanley said shares are cheap and recommends purchase.
07:19 EDTBACbloomberg to hold a summit
Subscribe for More Information
April 10, 2015
09:57 EDTBACBank of America April volatility elevated into Q1 and outlook
Subscribe for More Information
06:21 EDTBACBofA Merrill poaches JP Morgan's Brabazon for M&A group, Reuters reports
Subscribe for More Information
April 8, 2015
10:26 EDTBACBofA Merill Lynch names De Giorgi, Assef as investment banking co-heads, FT says
Subscribe for More Information
April 7, 2015
12:58 EDTOCNOn The Fly: Midday Wrap
Subscribe for More Information
11:02 EDTBACAmerican Express slips after analyst, columnist highlight challenges
Subscribe for More Information
09:23 EDTOCNOn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTBACRising competition may make AmEx targets hard to achieve, WSJ says
Though American Express recently reaffirmed its long-term targets for growing revenue 8% per year or better and earnings per share by 12%-15% per year while increasing operating expenses by less than 3% per year, there are good reasons to be skeptical about its ability to hit those targets, according to The Wall Street Journal's "Heard on the Street" column. Competition from peer Visa (V) as well as big banks such as Citi (C) and Bank of America (BAC) may put pressure on AmEx’s margins and it is not safe to assume that the company will always fare as well on the Fed's stress tests as it just did, the report stated. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use